Targeting ischemic brain injury with intravenous immunoglobulin

Author： Arumugam Thiruma V   Selvaraj Pradeep K   Woodruff Trent M   Mattson Mark P  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.1, 2008-01, pp. : 19-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells

By  

Current Pharmaceutical Design, Vol. 23, Iss. 26, 2017-10 ,pp. : 3899-3906

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenase Inhibition in Ischemic Brain Injury

By  

Current Pharmaceutical Design, Vol. 14, Iss. 14, 2008-05 ,pp. : 1401-1418

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 1, 2012-01 ,pp. : 46-58

Bentham Science Publishers

Access to resources Recommend Favorite

Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation

By Calapai G.   Marciano M.C.   Corica F.   Allegra A.   Parisi A.   Frisina N.   Caputi A.P.   Buemi M.  

European Journal of Pharmacology, Vol. 401, Iss. 3, 2000-08 ,pp. : 349-356

Elsevier

Access to resources Recommend Favorite

Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury

By  

Current Neuropharmacology, Vol. 8, Iss. 4, 2010-12 ,pp. : 324-334

Bentham Science Publishers

Access to resources Recommend Favorite